diagnostic solutions for infectious diseases. Optorain has obtained many intellectual property rights both in domestic and international markets, covering its foundational technology, semiconductor sensors, and its advanced technology, fusion bio-diagnostic technology. The flagship offering of Optorain is a highly sensitive digital PCR, which employs CMOS semiconductor sensors to execute PCR technology that amplifies genes present in samples and detects them through fluorescence.